2nd Bellwether Jury Says AbbVie Owes AndroGel User $140M
Law360, Chicago (October 5, 2017, 5:30 PM EDT) -- An Illinois federal jury ordered AbbVie Inc. to pay an AndroGel user more than $140 million Thursday after finding the company failed to test its testosterone gel product properly for cardiovascular risks and misrepresented what it was safe to treat.
Jeffrey Konrad was awarded $140,000 in compensatory damages and $140 million in punitive damages Thursday in his case against AbbVie over testosterone gel product Androgel. (Getty) The verdict came at the end of a nearly two-week trial in the second bellwether case in the multidistrict litigation over testosterone gel products. Plaintiff Jeffrey Konrad sued AbbVie five years after he suffered a...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!